Nizar Jarjour is a Respiratory physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 377 publications with 23,594 citations (h-index 73); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 Highland Ave
Madison, WI 53792
Telephone
608-263-7206Provider last certified this registry record 13 Jan 2021.
Clinical trials
- University of Wisconsin Severe Asthma Research Program III
Sponsor: University of Wisconsin, Madison
- Eosinophilic Airway Inflammation and Mepolizumab
Sponsor: University of Wisconsin, Madison
- Normal Control Cohort Sample Bank
Sponsor: University of Wisconsin, Madison
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202413 payments
- Chiesi USA, Inc.Program year20246 payments
- AstraZeneca Pharmaceuticals LPProgram year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%Leukotriene Receptor Antagonist52.2%Montelukast Sodium100%Part D<11 patientsCorticosteroid47.8%Trelegy Ellipta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
12 NIH research awards on record, funded 1993–2026 per NIH RePORTER. The latest:
- Investigating the mechanisms by which systemic inflammation promotes Alzheimer’s disease: Asthma as a model and modifiable risk factor
University of Wisconsin-Madison
FY2026$733,254R01AG082215 - Investigating the mechanisms by which systemic inflammation promotes Alzheimer’s disease: Asthma as a model and modifiable risk factor
University of Wisconsin-Madison
FY2023$2,261,120RF1AG082215
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mucus Plugs Persist in Asthma, and Changes in Mucus Plugs Associate with Changes in Airflow over Time
American Journal of Respiratory and Critical Care Medicine
2022 - COVID-19–related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids
American Journal of Respiratory and Critical Care Medicine
2020 - Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency
American Journal of Respiratory and Critical Care Medicine
2020 - Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
European Respiratory Journal
2019 - Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma
American Journal of Respiratory and Critical Care Medicine
2019
Similar KOLs
Other experts from the same institution or the same specialty.
William Busse, MD
University of Wisconsin–Madison
David Andes, MD
University of Wisconsin–Madison
Neil Binkley, MD
University of Wisconsin–Madison
Robert Lemanske, MD
University of Wisconsin–Madison
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”